ARGININE-VASOPRESSIN FRAGMENT 4-9 STIMULATES THE ACETYLCHOLINE-RELEASE IN HIPPOCAMPUS OF FREELY-MOVING RATS

被引:27
作者
MAEGAWA, H
KATSUBE, N
OKEGAWA, T
AISHITA, H
KAWASAKI, A
机构
[1] CNS Division, Preclinical Research Department, Minase Research Institute, Mishima, Osaka, 618, 3-1-1 Sakurai, Shimamoto
关键词
D O I
10.1016/0024-3205(92)90087-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the effects of arginine-vasopressin (AVP) C-terminal fragment 4-9, which facilitates learning and memory, on the extracellular acetylcholine (ACh) release in hippocampus of freely-moving rats using the microdialysis technique. Following administration of AVP4-9, p-Glu-Asn-Cys[Cys]-Pro-Arg-Gly-NH2, through the dialysis probe into the hippocampus, ACh levels in dialysates from the hippocampus increased markedly in dose and time dependent manner at 2-2.5 and 2.5-3 Ahr. AVP1-9, the parent peptide, has a similar enhancing effect on ACH release as AVP4-9. Stimulated ACh release by AVP4-9 was significantly inhibited by V1-selective receptor antagonist ([1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid), 2-(O-methyl)-tyrosine]AVP), but not by V2-selective antagonist ([1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid), 2-D-Ile, 4-Ile]AVP). From these observations, it is demonstrated that AVP4-9 stimulates the ACh release in rat hippocampus via mediating V1-like vasopressin receptors.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 36 条
  • [11] DIFFERENTIAL-EFFECTS OF 4-AMINOPYRIDINE AND 2,4-DIAMINOPYRIDINE ON THE INVIVO RELEASE OF ACETYLCHOLINE AND DOPAMINE IN FREELY MOVING RATS MEASURED BY INTRASTRIATAL DIALYSIS
    DAMSMA, G
    BIESSELS, PTM
    WESTERINK, BHC
    DEVRIES, JB
    HORN, AS
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 145 (01) : 15 - 20
  • [12] A SIMPLE, SENSITIVE, AND ECONOMIC ASSAY FOR CHOLINE AND ACETYLCHOLINE USING HPLC, AND ENZYME REACTOR, AND AN ELECTROCHEMICAL DETECTOR
    DAMSMA, G
    WESTERINK, BHC
    HORN, AS
    [J]. JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) : 1649 - 1652
  • [13] CENTRAL TARGET FOR THE BEHAVIORAL-EFFECTS OF VASOPRESSIN NEUROPEPTIDES
    DEWIED, D
    GAFFORI, O
    VANREE, JM
    DEJONG, W
    [J]. NATURE, 1984, 308 (5956) : 276 - 278
  • [14] MECAMYLAMINE PREVENTS THE ENHANCEMENT OF RETENTION INDUCED BY LYSINE VASOPRESSIN IN MICE
    FAIMAN, CP
    DEERAUSQUIN, GA
    BARATTI, CM
    [J]. BEHAVIORAL AND NEURAL BIOLOGY, 1987, 48 (03): : 434 - 439
  • [15] ARGININE VASOPRESSIN INDUCES THE EXPRESSION OF C-FOS IN THE MOUSE SEPTUM AND HIPPOCAMPUS
    GIRI, PR
    DAVE, JR
    TABAKOFF, B
    HOFFMAN, PL
    [J]. MOLECULAR BRAIN RESEARCH, 1990, 7 (02): : 131 - 137
  • [16] GREIDANUS TBV, 1983, PHARMACOL THERAPEUT, V20, P437
  • [17] KENDRICK KM, 1989, METHOD ENZYMOL, V168, P182
  • [18] MICRO-INJECTION OF ARGININE8-VASOPRESSIN ANTISERUM INTO THE DORSAL HIPPOCAMPUS ATTENUATES PASSIVE-AVOIDANCE BEHAVIOR IN RATS
    KOVACS, GL
    BUIJS, RM
    BOHUS, B
    GREIDANUS, TBV
    [J]. PHYSIOLOGY & BEHAVIOR, 1982, 28 (01) : 45 - 48
  • [19] FACILITATION OF AVOIDANCE-BEHAVIOR BY VASOPRESSIN FRAGMENTS MICROINJECTED INTO LIMBIC-MIDBRAIN STRUCTURES
    KOVACS, GL
    VELDHUIS, HD
    VERSTEEG, DHG
    DEWIED, D
    [J]. BRAIN RESEARCH, 1986, 371 (01) : 17 - 24
  • [20] ARGININE-VASOPRESSIN CONTENT OF HIPPOCAMPUS AND AMYGDALA DURING PASSIVE-AVOIDANCE BEHAVIOR IN RATS
    LACZI, F
    GAFFORI, O
    DEKLOET, ER
    DEWIED, D
    [J]. BRAIN RESEARCH, 1983, 280 (02) : 309 - 315